BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 18472700)

  • 1. Management of patients with breast cancer: are we ready in India for sentinel lymph node biopsy?
    Deo SV; Varma MC; Shukla NK
    Natl Med J India; 2008; 21(1):27-30. PubMed ID: 18472700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node in the era of neoadjuvant therapy and locally advanced breast cancer.
    Trocha SD; Giuliano AE
    Surg Oncol; 2003 Dec; 12(4):271-6. PubMed ID: 14998567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of use of a clinicopathological score to select patients for the type of axillary surgery.
    Pinkney TD; Nightingale P; Carmichael AR
    Eur J Surg Oncol; 2007 Mar; 33(2):153-6. PubMed ID: 17097850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches in breast cancer management: sentinel node biopsy and intraoperative radiotherapy.
    Keshtgar MR; Chicken DW; Tobias JS
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):218-26. PubMed ID: 16468472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast cancer: axillary dissection--or an unnecessary procedure?].
    Schäfer P
    Schweiz Med Wochenschr; 1998 Oct; 128(43):1667-74. PubMed ID: 9842666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach.
    Samphao S; Eremin JM; El-Sheemy M; Eremin O
    Ann Surg Oncol; 2008 May; 15(5):1282-96. PubMed ID: 18330650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of sentinel lymph node biopsy in early breast cancer.
    Jatoi I
    Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node in breast cancer.
    James TA; Edge SB
    Curr Opin Obstet Gynecol; 2006 Feb; 18(1):53-8. PubMed ID: 16493261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel node biopsy in breast cancer].
    Imoto S; Wada N; Hasebe T; Ebihara S
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1120-4. PubMed ID: 12145990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of sentinel node biopsy in breast cancer surgery].
    Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
    Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in the management of breast cancer.
    Kumar R; Bozkurt MF; Zhuang H; Alavi A
    Indian J Cancer; 2003; 40(2):60-6. PubMed ID: 14716120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is axillary dissection needed in node-positive breast cancer?
    Greenberg CC; Bafford AC; Golshan M
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):195-8. PubMed ID: 18279060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary management after sentinel lymph node biopsy in breast cancer patients.
    Rivers A; Hansen N
    Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of axillary lymph node metastasis in breast cancer.
    Wasuthit Y; Kongdan Y; Suvikapakornkul R; Lertsithichai P; Chirappapha P
    J Med Assoc Thai; 2011 Jan; 94(1):65-70. PubMed ID: 21425730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of sentinel node-positive breast cancer.
    Chagpar AB; McMasters KM
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1233-9. PubMed ID: 16925489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.